- Home
- ELTX vs CKPT Comparison
ELTX vs CKPT Comparison
Compare ELTX & CKPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELTX
- CKPT
- Stock Information
- Founded
- ELTX 2011
- CKPT 2014
- Country
- ELTX United States
- CKPT United States
- Employees
- ELTX N/A
- CKPT N/A
- Industry
- ELTX Biotechnology: Pharmaceutical Preparations
- CKPT Biotechnology: Pharmaceutical Preparations
- Sector
- ELTX Health Care
- CKPT Health Care
- Exchange
- ELTX Nasdaq
- CKPT Nasdaq
- Market Cap
- ELTX 49.7M
- CKPT N/A
- IPO Year
- ELTX 2021
- CKPT 2017
- Fundamental
- Price
- ELTX $4.16
- CKPT $3.77
- Analyst Decision
- ELTX Buy
- CKPT Strong Buy
- Analyst Count
- ELTX 2
- CKPT 2
- Target Price
- ELTX $10.00
- CKPT $12.00
- AVG Volume (30 Days)
- ELTX 16.1K
- CKPT 946.5K
- Earning Date
- ELTX 11-07-2024
- CKPT 11-11-2024
- Dividend Yield
- ELTX N/A
- CKPT N/A
- EPS Growth
- ELTX N/A
- CKPT N/A
- EPS
- ELTX N/A
- CKPT N/A
- Revenue
- ELTX N/A
- CKPT $78,000.00
- Revenue This Year
- ELTX N/A
- CKPT N/A
- Revenue Next Year
- ELTX N/A
- CKPT $151,162.55
- P/E Ratio
- ELTX N/A
- CKPT N/A
- Revenue Growth
- ELTX N/A
- CKPT N/A
- 52 Week Low
- ELTX $2.96
- CKPT $1.36
- 52 Week High
- ELTX $11.45
- CKPT $3.95
- Technical
- Relative Strength Index (RSI)
- ELTX 40.82
- CKPT 84.67
- Support Level
- ELTX $4.05
- CKPT $2.37
- Resistance Level
- ELTX $4.89
- CKPT $2.54
- Average True Range (ATR)
- ELTX 0.28
- CKPT 0.27
- MACD
- ELTX -0.06
- CKPT 0.10
- Stochastic Oscillator
- ELTX 27.37
- CKPT 88.60
About ELTX Elicio Therapeutics Inc.
Elicio Therapeutics Inc is a clinical-stage biotechnology company pioneering the development of cancer immunotherapies for patients with limited treatment options and poor outcomes. Its proprietary Amphiphile, or AMP, platform delivers investigational immunotherapeutics directly to the brain center of the immune system the lymph nodes. Its focus is the development of cancer immunotherapies against biologically validated but hard-to-drug targets that can be activated through lymph node trafficking. Elicio is engineering lymph node-targeted AMPlifiers, immunomodulators, adjuvants, and vaccines for an array of aggressive cancers. It has developed its cancer vaccine product candidates to target biologically validated tumor mutation drivers using known neoantigens.